Juan Carlos Tercero

Title: Juan Carlos Tercero: Innovator in Breast Cancer Treatment

Introduction

Juan Carlos Tercero is a prominent inventor based in Madrid, Spain. He has made significant contributions to the field of medical treatments, particularly in the area of breast cancer therapy. With a total of 4 patents to his name, Tercero is recognized for his innovative approaches to personalized medicine.

Latest Patents

One of Tercero's latest patents focuses on a therapeutic treatment of breast cancer based on c-MAF status. This invention relates to designing a customized therapy for individuals with breast cancer, taking into account the c-MAF expression level and the menopausal status of the subject. In some embodiments, the customized therapy includes an agent for avoiding, treating, or preventing bone degradation. Specifically, the agent may be zoledronic acid, clodronate, or denosumab. This innovative approach aims to enhance treatment efficacy and improve patient outcomes.

Career Highlights

Juan Carlos Tercero is associated with Inbiomotion S.L., a company dedicated to advancing cancer treatment solutions. His work at Inbiomotion has allowed him to collaborate with leading experts in the field, further enhancing his contributions to medical science.

Collaborations

Tercero has worked alongside notable colleagues such as Roger Gomis and Walter Martin Gregory. These collaborations have played a crucial role in the development of his innovative therapies and have contributed to the advancement of cancer treatment methodologies.

Conclusion

Juan Carlos Tercero's work in developing personalized therapies for breast cancer showcases his commitment to improving patient care through innovation. His contributions to the field are significant and continue to influence the future of cancer treatment.